Patent details

Basic Information

Publication number:

EP4251244

PCT Application Number:

EP2021081716

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP218071249

PCT Publication Number:

WO2022112043

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

RATE-LIMITED SYRINGE

French Title of Invention:

SERINGUE À DÉBIT LIMITÉ

German Title of Invention:

SPRITZE MIT BEGRENZTER RATE

SPC Number:

Dates

Filing date:

15/11/2021

Grant date:

15/04/2026

EP Publication Date:

04/10/2023

PCT Publication Date:

02/06/2022

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/04/2026

EP B1 Publication Date:

15/04/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/11/2041

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/04/2026

 

 

Name:

Teva Pharmaceuticals International GmbH

Address:

Schlüsselstrasse 12, 8645 Jona, Switzerland (CH)

Inventor

1

Name:

WALDRON, Alexander

Address:

United Kingdom (GB)

2

Name:

IRIVN, James

Address:

United Kingdom (GB)

3

Name:

WALLER, Jonathan

Address:

United Kingdom (GB)

Priority

Priority Number:

20210081

Priority Date:

26/11/2020

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61M 5/178; A61M 5/315; A61M 5/48; A61K 31/551;

Publication

European Patent Bulletin

Issue number:

202616

Publication date:

15/04/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/11/2026

Annual Fee Number:

6

Annual Fee Amount:

66 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages